In its preliminary unaudited fourth quarter revenue report, lumbar spine device company TranS1 saw $4.1 million in revenue, a 3 percent increase from the fourth quarter of 2011.
The revenue also represents a 39 percent increase from revenues in the third quarter of 2012. Domestic revenues from 2012 fourth quarter are approximately $3 million with international revenue at $1.1 million.
In 2013, providers can begin using the new Category 1 code for the company's AxiaLIF technology.
More Articles on Devices:
ArthroCAD Completes Financing Round for Total Hip Arthroplasty Development
Hydrocision's Spine Device Now Available for Herniated Disc Pain Relief
FDA Grants Clearance to Two VertiFlex Spine Systems
In 2013, providers can begin using the new Category 1 code for the company's AxiaLIF technology.
More Articles on Devices:
ArthroCAD Completes Financing Round for Total Hip Arthroplasty Development
Hydrocision's Spine Device Now Available for Herniated Disc Pain Relief
FDA Grants Clearance to Two VertiFlex Spine Systems